Skip to main content
The William Harvey Research Institute - Faculty of Medicine and Dentistry

2018

Genomics project reaches goal of 100,000 genomes sequenced from NHS patients
6 December 2018

UK Health Secretary Matt Hancock has today announced that a project involving Queen Mary University of London researchers has reached its goal of sequencing 100,000 whole genomes from NHS patients.

WHRI researchers in top 1 per cent worldwide
27 November 2018

Three researchers from the William Research Institute have been placed in the top 1 per cent in the world, in this year’s Highly Cited Researchers list.

Research in Focus
22 November 2018

Dr Gloria Lliso-Ribera, Rheumatology Clinical Research Fellow

Professor Chris Thiemermann honoured for his contributions to science
8 November 2018

In October 2018, Chris Thiemermann, Professor of Pharmacology and Centre Lead for Translational Medicine & Therapeutics at the William Harvey Research Institute, received the prestigious Albert Nelson Marquis Lifetime Achievement Award.

Professor Márta Korbonits delivers inaugural Lady Estelle Wolfson lecture at the RCP
29 October 2018

Professor Márta Korbonits gave the Lady Estelle Wolfson lecture in translational medicine at the Royal College of Physicians on the 24th October 2018 during the Acute and General Medicine Conference.

Genetic tool to predict adult heart attack risk in childhood
10 October 2018

People at high risk of a heart attack in adulthood could be identified much earlier in life with a one-off DNA test, according to new research published in the Journal of the American College of Cardiology.

Landmark TB research announced at the UN General Assembly
27 September 2018

A landmark international research project, involving researchers from Queen Mary University of London, has shown that we can now use our knowledge of the tuberculosis (TB) genetic code to predict which drugs are best for treating a patient’s infection.

Researchers awarded for lifetime achievements in blood pressure research
24 September 2018

Two academics from Queen Mary University of London have received prestigious awards from the International Society of Hypertension (ISH) in recognition of their achievements in blood pressure research.

Study of one million people leads to world’s biggest advance in blood pressure genetics
17 September 2018

Over 500 new gene regions that influence people’s blood pressure have been discovered in the largest global genetic study of blood pressure to date, led by Queen Mary University of London and Imperial College London.

Blood pressure medications and statins found to provide long-term cardiovascular benefits
28 August 2018

Death rates from heart disease and stroke could be significantly lowered by prescribing statins alongside blood pressure-lowering drugs, according to the results from a clinical trial led by Queen Mary University of London and Imperial College London.

New research links low levels of air pollution with serious changes in the heart
3 August 2018

Researchers from Queen Mary University of London have found that people exposed to air pollution levels well within UK guidelines have changes in the structure of the heart, similar to those seen in the early stages of heart failure.

ESE’s Scientific Programme Chair discusses Brexit effects on European Reference Network in the UK Parliament
6 July 2018

Professor Márta Korbonits, Professor of Endocrinology at Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Scientific Programme Chair of the European Society of Endocrinology, and representative of BioMed Alliance, will be discussing the effects of Brexit on the European Reference Networks (ERNs), in Westminster, Monday 9 July.

Q&A with Dr Li Chan
7 June 2018

Research paper: MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation

New lab technology could reveal treatments for muscle-wasting disease
6 June 2018

Researchers from Queen Mary University of London have developed new cell-based technologies which could improve understanding of the muscle-wasting disease Duchenne muscular dystrophy (DMD) and test potential drugs for the disease.

Surgery involving ultrasound energy found to treat high blood pressure
23 May 2018

An operation that targets the nerves connected to the kidney has been found to significantly reduce blood pressure in patients with hypertension, according to the results of a clinical trial led in the UK by Queen Mary University of London and Barts Health NHS Trust, and supported by the National Institute for Health Research (NIHR).

Lunch & Learn: Cutting Edge Studies in Autoimmune Disease
18 May 2018

Date: 1 June 2018
Time: 12:00pm
Venue: William Harvey Research Institute, Charterhouse Square Campus

QMUL and UCL joint study identifies genes linked to impaired capacity to modulate heart rate during and after exercise
17 May 2018

A new study by researchers at Queen Mary University of London (QMUL) and University College London (UCL) has discovered 30 new gene locations that determine how the heart responds to and recovers from exercise.

Fellows inaugurated at new Rutherford Academy of Population Genomics and Health Data Science
14 May 2018

Queen Mary University of London has appointed four postdoctoral research fellows to its new Rutherford Academy of Population Genomics and Health Data Science, funded by the Medical Research Council and UK Research and Innovation’s Rutherford Fund. One of the fellows include WHRI's Dr Adriano Barbosa.

Professor Panos Deloukas elected as Fellow of The Academy of Medical Sciences
10 May 2018

Professor of Cardiovascular Genomics at Queen Mary University of London has been recognised for his outstanding contribution to genomic medicine. 

Professor Gustav Born: 29th July 1921- 16 April 2018
25 April 2018

A message sent on behalf of Professor Steve Thornton, Vice Principal (Health)

Pint of Science Festival, 14-16 May 2018
13 April 2018

Pint of Science QMUL brings scientists out of the lab and in to your local pub.

Hormone imbalance causes treatment-resistant hypertension
12 April 2018

British researchers have discovered a hormone imbalance that explains why it is very difficult to control blood pressure in around 10 per cent of hypertension patients.

New project to transform treatment for children with arthritis
28 March 2018

Researchers from Queen Mary University of London will join a UK-wide effort to drive the development of new treatments for children and young people with juvenile idiopathic arthritis (JIA) and its associated eye-inflammation condition, uveitis.

Weak hand grip could be sign of a failing heart
15 March 2018

Hand grip strength could be used as a simple measure of heart health, according to new research led by scientists at Queen Mary University of London.

Menopausal hormone therapy linked to having a healthier heart
9 March 2018

Women who use menopausal hormone therapy appear to have a heart structure and function that is linked to a lower risk of heart failure, according to a study led by Queen Mary University of London.

New insights into why patients have a higher risk of heart attack in the morning
8 March 2018

Cardiovascular disease patients have lower levels of an important family of protective molecules in their blood in the morning, which could be increasing their risk of blood clots and heart attacks at those times, according to early research led by Queen Mary University of London.

Aspirin helps treat tuberculous meningitis
7 March 2018

The painkiller aspirin appears to reduce the risk of stroke and death in patients with the most deadly form of tuberculosis, according to a study by Queen Mary University of London, Oxford University Clinical Research Unit (Vietnam), Western General Hospital and University of Oxford.

Isolated white blood cell packages from patients with rheumatoid arthritis shown to be protective against inflammation
1 March 2018

A new study by researchers from Queen Mary University of London finds that small packages released by white blood cells during inflammation can be used to prevent the activation of other white blood cells.  

Dr Suchita Nadkarni's 'The Placenta Rainbow' featured in National Geographic
27 February 2018

Photo by William Harvey Research Institute (WHRI) and British Heart Foundation (BHF) Research Fellow shows differences in mouse placental development that can result from manipulation of the mother’s immune system.

“Beetroot pill” could help save patients from kidney failure after heart x-ray
22 February 2018

Beetroot may reduce the risk of kidney failure in patients having a heart x-ray, according to research led by Queen Mary University of London.

£54 million award to transform health through data science
7 February 2018

Queen Mary University of London has partnered with four other London universities - UCL, Imperial College London, King's College London and The London School of Hygiene & Tropical Medicine - in a new initiative to transform health through data science.

100,000 Genomes Project to sequence its 500th genome later this month
6 February 2018

Professor Mark Caulfield spoke to Observer Science Editor Robin McKie about the pioneering work of the 100,000 Genomes Project as it approaches its halfway point.

Multinational companies continue to produce unregulated antibiotics in India
6 February 2018

Millions of unapproved antibiotics are being sold in India, according to a new joint study led by Dr Patricia McGettigan from the William Harvey Research Institute.

The first step in generating an artificial adrenal gland
31 January 2018

In a new study, published in Cell Reports, researchers from Queen Mary University of London used cells derived from urine to take the first step in generating an artificial adrenal gland, which could help develop future treatments for adrenal gland disorders.

 Diabetes-gene-found-that-causes-low-and-high-blood-sugar-levels-in-the-same-family Diabetes gene found that causes low and high blood sugar levels in the same family
16 January 2018

A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

 

Back to top